Kalbe Farma | Mutual Funds
Mutual Funds that own Kalbe Farma
First State Investments ICVC - Asia Pacific Leaders Fund
993,079,900
2.12%
209,069,800
0.77%
01/31/2018
Vanguard Emerging Markets Stock Index Fund
287,741,936
0.61%
-2,401,000
0.03%
07/31/2018
MFS International New Discovery Fund
285,957,000
0.61%
0
0.4%
07/31/2018
RBC Emerging Markets Equity Fund
277,742,400
0.59%
7,742,400
1.02%
06/30/2017
Vanguard Total International Stock Index Fund
260,698,954
0.56%
0
0.01%
07/31/2018
Schroder Dana Prestasi Plus
240,587,000
0.51%
240,587,000
1.92%
12/31/2016
iShares Core MSCI Emerging Markets ETF
183,120,100
0.39%
0
0.03%
09/05/2018
iShares MSCI Emerging Markets Minimum Volatility ETF
166,740,800
0.36%
0
0.33%
09/06/2018
Mirae Asset Glb. Discovery Fd. - Asia Great Consumer Equity
146,985,672
0.31%
-31,555,900
2.57%
09/30/2017
JPMorgan Funds - Asean Fund
141,301,300
0.3%
34,403,400
0.81%
03/31/2018
| Address |
Gedung KALBE
Jakarta JK 10510
Indonesia
|
|
Employees
|
- |
| Website |
http://www.kalbe.co.id |
| Updated |
07/08/2019 |
| PT Kalbe Farma Tbk engages in the development, production, distribution, and trade of pharmaceutical products. It operates through the following segments: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. The Prescription Pharmaceutical segment offers generic drugs, branded generics, and licensed drugs, which are distributed to hospitals, pharmacies, and drug stores throughout Indonesia. |
